期刊文献+

法舒地尔对急性心肌梗死大鼠心肌的保护作用 被引量:17

Fasudil protects the myocardium in rats with acute myocardial infarction
原文传递
导出
摘要 目的:通过检测急性心肌梗死(AMI)大鼠左心室梗死面积及缺血区凋亡细胞来评价法舒地尔对大鼠AMI后心肌的保护作用。方法:雌性Wistar大鼠随机分为3组,AMI组:结扎左前降支(LAD);治疗组:术前1 h法舒地尔30 mg/kg腹腔注射,结扎LAD;假手术组:仅在LAD下穿线但不结扎。术后24 h,伊文蓝-红四氮唑双染色,确定缺血面积和梗死面积,TUNEL法检测缺血区凋亡细胞,免疫组织化学染色法检测缺血区bcl-2和bax的表达,逆转录-聚合酶链式反应测定Rho激酶mRNA的表达。结果:治疗组与AMI组比较,梗死面积显著减小(26.04±2.51)%∶(32.27±3.07)%,P<0.01,缺血面积差异无统计学意义。AMI组与假手术组比较,凋亡指数明显增加(31.94±3.03)∶(2.44±1.37),P<0.01,bcl-2表达降低,bax表达增加,Rho激酶mRNA表达增加(均P<0.01)。而治疗组与AMI组比较,凋亡指数显著降低,bcl-2表达增加,bax表达降低,Rho激酶mR-NA表达降低,均P<0.01。结论:Rho激酶参与了AMI心肌细胞的凋亡,法舒地尔的心肌保护作用与其抗心肌细胞凋亡效应有关。 Objective:To study the effects of fasudil, a Rho-kinase inhibitor, on protection the myocardium in rats with acute myocardial infarction(AMI). Method:Twenty-nine female wistar rats were subjected to left anterior descending coronary artery(LAD) ligation and were divided randomly into three groups: sham operation group (not ligation of LAD), AMI group and treated group. 1 h before surgery the rats were received normal saline 0.5 ml(sham group and AMI group)and 30 mg/kg fasudil(treated group). At 24 hours after coronary ligation, the rats were sacrificed. The infarct size and ischemia size were determined by evans-hule and TTC double staining. The apoptotic cardiocyte in the ischemia region was determined by TUNEL assay and the apoptotic index(AI) were calculated. The hcl-2 and hax protein expressions were measured by immunohistochemical staining. The Rho-kinase mRNA expression in the ischemia region was measured by RT-PCR. Result: The infarct size was reduced obviously in treated group compared with AMI group(26.04±2. 51)% : (32. 27±3.07)% ,P〈0.01. The AI significantly increased in AMI group compared with sham group, (31.94 ± 3.03)% : (2.44 ± 1.37)%, P〈 0.01, and in treated group the AI reduced sharply ( 18.39 ± 1.53) %. The overexpression of Rho-kinase mRNA was attenuated by Rho-kinase. Meanwhile AMI induced downregulation of bcl-2 and upregulation of bax in myocardium was remarkably attenuated in the treated animals. Conclusion: Rho-kinase plays an important role in cardiocyte apoptosis induced by AMI and fasudil provides cardiac protection via anti-apoptotic effect.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第7期537-539,共3页 Journal of Clinical Cardiology
关键词 心肌梗死 法舒地尔 细胞凋亡 Myocardial infarction Fasudil Cell apoptosis
  • 相关文献

参考文献13

  • 1陈跃峰,杨跃进.急性心肌梗死后心室重塑——心肌细胞凋亡的意义[J].中华心血管病杂志,2003,31(8):629-631. 被引量:16
  • 2RIENTO K, RIDLEY A J. Rocks: multifunctional kinases in cell behaviour[J]. Nat Rev Mol Cell Biol, 2003,4 :446 - 456.
  • 3SHIOTANI S, SHIMADA M, SUEHIRO T, et al Involvement of Rho-kinase in cold ischemia-reperfu sion injury after liver transplantation in rats [J] .Transplantation, 2004,78 : 375 - 382.
  • 4尹瑞兴,李佳荃,蔡捷,杨德寨.血管内皮生长因子对急性心肌梗死大鼠心肌细胞凋亡的影响[J].中华老年医学杂志,2003,22(2):98-101. 被引量:9
  • 5杨光敏,曹林生,王祥,曾秋棠,聂绍平,李长运,王祥贵,张清伟,刘宏宇.针刺心肌打孔与激光心肌血运重建术对急性心肌缺血的影响[J].临床心血管病杂志,2004,20(1):36-38. 被引量:4
  • 6SHIMOKAWA H, TAKESHITA A. Rho-kinase is an important therapeutic target in cardiovascular medicine[J]. Arterioscler Thromb Vasc Biol, 2005, 25: 1767-1775.
  • 7SHIMOKAWA H, HIRAMORI K, IINUMA H, et al. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study[J]. J Cardiovasc Pharmacol, 2002, 40:751-761.
  • 8VICARI R M, CHAITMAN B, KEEFE D, et al. Efficacy and safety of fasudil in patients with stable an gina: a double-blind, placebo-controlled, phase 2 trial [J]. J AmCollCardiol, 2005, 46,1803-1811.
  • 9HATTORI T, SHIMOKAWA H, HIGASHI M, et al. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice[J]. Circulation, 2004, 109:2234-2239.
  • 10KAJSTURA J, CHENG W. REISS K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats[J]. Lab Invest, 1996, 74:86-107.

二级参考文献46

  • 1[1]Kavanagh G J, Whittaker P, Prejean C A, et al. Dissociation between improvement in angina pectoris and myocardial perfusion after transmyocardial revascularization with an excimer laser. Am J Cardiol, 2001,87:229-231.
  • 2[2]Horvath K A, Cohn L H, Cooley D A, et al. Transmyocardial laser resvacularization: result of a multicenter trial with transmyocardial laser revascula-rization used as sole therapy for end-stage coronary artery disease. J Thorac Surg,1997,113: 645-654.
  • 3[3]Jones M S, Latchman D C, Walker J M, et al. Cardiac stress protein 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarc-tion. Circulation , 1993,88:1265-1265.
  • 4[4]Gassler N, Wintzer H O, Stubbe H M, et al. Transmyocardial laser revascularization: Histological features in human nonresponder myocardium. Circulaiton, 1997,95:371-375.
  • 5[5]Jansen E D, Frenz M, Kadipasaoglu K A, et al. Laser tissue interaction during transmyocardial laser revascularization. Ann Thorac Surg, 1997,63:640-647.
  • 6[6]Kohmoto T, Uzun G, Gu A, et al. Blood flow capacity via direct acute myocardial revascularization. Basic Res Cardiol, 1997, 92:45-51.
  • 7[7]Whittakes P. Detection and assessment of laser mediated injury in transmyocardial revasculization. J Clin Laser Med Surg, 1997,15:261-267.
  • 8[8]Malekan R, Reynolds C, Narula N, et al. Angiogenesis in transmyocardial laser revascularization: a nonspecific response to injury. Circulation, 1998,98(19 Suppl):Ⅱ62-65.
  • 9[9]Chu V F, Giaid A, Kuang J Q, et al. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures. Ann Thorac Surg, 1999, 68:301-308.
  • 10[10]Fisher S E, Franme J W, Browne R M, et al. A comparative histologic study of wound healing following CO2 laser and conventional surgical excision of canine buccal mucosa.Arch Oral Biol,1983,28:287-291.

共引文献26

同被引文献197

引证文献17

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部